Ironwood Pharmaceuticals, Inc. logo IRWD - Ironwood Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 11
HOLD 16
SELL 3
STRONG
SELL
0
| PRICE TARGET: $4.80 DETAILS
HIGH: $5.70
LOW: $3.70
MEDIAN: $5.00
CONSENSUS: $4.80
UPSIDE: 22.45%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
Revenue
Revenue 296.2 351.4 442.7 410.6 413.8 389.5 428.4 346.6 298.3 274.0 149.6 76.4 22.9 150.2 65.9 43.9 36.1 22.2 10.5 3.1
Cost of Revenue 0 7.6 6.1 1.4 70.4 3.1 135.4 32.8 19.4 1.9 0.0 25.6 7.2 1.0 0 0 0 0 0 3.1
Gross Profit 296.2 343.9 436.6 409.2 343.3 386.4 293.0 313.9 278.9 272.1 149.5 50.9 15.7 149.3 65.9 43.9 36.1 22.2 10.5 0
Operating Expenses
R&D Expenses 95.1 111.4 116.1 44.3 70.4 88.1 122.2 166.5 148.2 139.5 108.7 101.9 102.4 113.5 86.1 77.5 84.9 59.8 57.2 35.5
SG&A Expenses 82.3 0 0 116.0 0 140.0 0 241.3 233.1 173.3 125.2 118.3 123.2 92.5 45.9 27.2 24.0 18.3 10.8 5.9
Other Expenses 0 139.3 1,265.9 (1.4) 40.7 15.4 50.7 8.1 6.2 1.0 0 0.7 42.1 16.0 0 0 0 0 0 0
Operating Expenses 177.4 250.7 1,382.0 158.8 111.1 243.4 172.9 415.9 387.6 313.8 234.0 220.2 267.7 222.0 132.0 104.6 108.9 78.1 68.1 41.5
Operating Income
Operating Income 118.8 93.1 (945.4) 250.3 232.3 142.9 120.1 (238.9) (77.4) (51.9) (102.1) (169.4) (252.0) (72.8) (66.1) (60.8) (72.8) (55.9) (57.6) (39.6)
Interest Expense 32.7 33.0 21.6 7.6 31.1 29.5 36.6 37.7 36.4 39.2 31.1 21.2 21.0 0.1 0.1 0.2 0.5 0.3 0.3 0.2
Interest Income 4.1 4.5 19.0 9.5 0.7 1.5 2.9 3.0 2.1 1.2 0.4 0.3 0.2 0.2 0.5 0.6 0.2 2.1 4.1 2.5
Profitability
EBITDA 104.7 97.7 197.4 261.4 233.7 141.9 128.6 (144.5) (33.1) (31.3) (99.9) (156.1) (240.1) (61.2) (54.8) (53.0) (67.3) (51.8) (51.2) (35.8)
EBIT 102.8 95.7 195.8 260.0 232.2 138.3 123.0 (156.4) (18.5) (42.6) (111.6) (168.5) (251.8) (72.6) (64.8) (59.2) (60.0) (54.7) (52.9) (37.1)
Income Before Tax 70.0 65.2 (948.1) 252.4 200.7 108.9 58.9 (282.4) (116.9) (81.7) (142.7) (189.6) (272.8) (72.6) (64.8) (59.4) (73.6) (55.0) (53.2) (37.3)
Income Tax Expense 46.0 64.3 83.5 77.4 (327.8) 2.7 0 (5.8) 34.3 0 0 0 0 0 0.0 (2.9) (0.3) 0 (0.1) 0
Net Income 24.0 0.9 (1,002.2) 175.1 528.4 106.2 21.5 (282.4) (116.9) (81.7) (142.7) (189.6) (272.8) (72.6) (64.9) (53.0) (71.2) (53.9) (52.8) (37.2)
Per Share Data
EPS (Basic) 0.15 0.01 -6.45 1.13 3.26 0.67 -0.10 -1.85 -0.79 -0.56 -1.00 -1.39 -2.35 -0.68 -0.65 -0.59 -10.00 -7.82 -7.41 -5.22
EPS (Diluted) 0.15 0.01 -6.45 0.96 3.21 0.66 -0.10 -1.85 -0.78 -0.56 -1.00 -1.39 -2.35 -0.68 -0.65 -0.59 -1.02 -0.77 -0.70 -0.39
Shares Outstanding 162.2 159.1 155.4 154.4 162.2 159.4 156.0 152.6 148.4 144.9 142.2 136.8 115.9 106.4 99.9 89.7 7.1 6.9 7.1 7.1
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2009 2008
Current Assets
Cash & Cash Equivalents 215.5 88.6 92.2 656.2 620.1 364.3 177.0 173.2 125.7 54.0 123.1 67.7
Short-Term Investments 0 0 0 0 0 0 0 0 95.7 251.2 0 22.0
Net Receivables 46.7 81.9 129.1 115.5 114.0 122.4 117.2 81.0 82.2 64.9 5.2 7.1
Inventory 0 0 0 1.2 0 0 0.6 0 0.7 1.1 0 2.5
Other Current Assets 12.0 11.9 0 0 2.4 9.2 1.2 2.1 0 0 3.1 8.7
Total Current Assets 274.2 182.4 233.3 780.6 745.2 495.8 306.9 266.4 311.6 380.2 131.4 108.1
Non-Current Assets
Property, Plant & Equipment 12.7 15.5 18.2 20.3 22.9 25.5 30.2 17.3 17.3 20.5 22.6 24.6
Goodwill 0 0 0 0 0 0 0.8 0.8 0.8 0.8 0 0
Intangible Assets 2.0 2.9 3.7 0 0 0 0 0 159.9 166.1 0 0
Long-Term Investments 0 0 0 15.1 0 37.0 0 47.4 115.2 140.8 0 0
Other Non-Current Assets 4.5 5.9 3.6 0.8 358.8 0.9 64.9 47.6 116.1 142.2 8.5 8.0
Total Non-Current Assets 122.7 168.5 237.8 319.9 381.7 63.4 95.9 65.6 294.1 329.6 31.0 32.6
Total Assets 396.9 350.9 471.1 1,100.5 1,126.9 559.2 402.7 332.1 605.7 709.8 162.5 140.7
Current Liabilities
Account Payables 2.9 2.1 7.8 0.5 0.9 0.7 5.5 14.9 16.0 17.7 4.8 3.7
Short-Term Debt 202.9 0 199.6 0 116.9 3.1 0 47.6 4.1 6.2 1.5 0.9
Deferred Revenue 0 2.0 2.6 0 0 0 0.9 0.3 0.2 7.7 32.7 18.0
Other Current Liabilities 35.5 5.0 26.1 15.9 7.5 15.0 14.9 42.0 23.2 42.5 15.3 28.6
Total Current Liabilities 242.2 38.8 276.1 25.5 161.7 32.2 40.9 119.5 66.0 91.1 56.4 39.2
Non-Current Liabilities
Long-Term Debt 385 584.0 498.3 396.3 337.3 430.3 408.0 366.1 396.1 366.6 1.8 0.9
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 (0.1) (0.2)
Other Non-Current Liabilities 21.6 17.1 28.4 9.8 3.5 13.9 25.0 42.6 133.7 185.3 308.8 273.4
Total Non-Current Liabilities 416.5 613.4 541.3 422.6 359.3 464.4 455.1 408.9 529.8 552.0 404.4 332.0
Total Liabilities 658.7 652.2 817.4 448.1 521.0 496.6 496.0 528.4 595.8 643.1 460.8 371.1
Stockholders' Equity
Common Stock 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.0 0.0
Retained Earnings (1,673.7) (1,697.7) (1,698.6) (696.4) (937.6) (1,466.1) (1,572.2) (1,591.1) (1,308.8) (1,191.8) (314.6) (243.4)
Accumulated Other Comprehensive Income (1.1) 0.9 (3.0) 0 0 0 (10.1) 0 (0.1) (0.0) (298.4) 0.0
Total Stockholders' Equity (261.8) (301.3) (346.3) 652.4 605.9 62.6 (93.3) (196.4) 9.8 66.7 (301.6) (235.8)
Total Liabilities & Equity 396.9 350.9 471.1 1,100.5 1,126.9 559.2 402.7 332.1 605.7 709.8 162.5 140.7
Debt Metrics
Total Debt 597.8 599.5 715.5 415.9 475.8 453.7 431.2 413.9 400.2 372.8 3.3 2.1
Net Debt 382.3 510.9 623.4 (240.3) (144.3) 89.4 254.2 240.8 274.4 318.8 (119.8) (65.6)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Operating Activities
Net Income 24.0 0.9 (1,002.2) 175.1 528.4 106.2 21.5 (282.4) (116.9) (81.7)
Depreciation & Amortization 1.9 2.0 1.6 1.4 1.5 3.6 5.6 14.2 14.6 11.3
Stock-Based Compensation 17.2 29.9 32.0 27.0 22.3 31.2 31.3 44.0 33.8 29.2
Change in Working Capital 39.6 0.7 11.3 2.8 17.7 (0.9) (100.0) 7.6 (21.8) (5.0)
Other Non-Cash Items 3.4 2.0 1,068.2 1.7 25.2 22.3 52.4 (13.4) (16.8) 28.1
Operating Cash Flow 127.0 103.5 183.4 273.8 261.9 168.8 10.7 (70.9) (99.6) (25.4)
Investing Activities
Capital Expenditure (0.0) (0.1) (0.3) (0.1) (0.3) (1.8) (7.2) (8.6) (4.2) (104.2)
Acquisitions 0 0 (1,026.0) 0 0 0 0 1.6 0.1 100
Purchases of Investments 0 0 0 0 0 0 0 (3.2) (191.4) (311.1)
Sales/Maturities of Investments 0 0 0 0 0 0 0 99.2 346.9 237.4
Other Investing Activities 0 0 0 0 0 0 (4.0) 1.6 0.1 (99.8)
Investing Cash Flow (0.0) (0.1) (1,026.3) (0.1) (0.3) (1.8) (11.1) 88.9 151.5 (177.7)
Financing Activities
Net Debt Issuance 0 (115) 300 (120.7) 0 0 19.4 (1.8) 8.8 (28.8)
Stock Repurchased 0 0 0 (126.4) (24.1) 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 (3.0) (29.2) 9.5 19.6 0 (20.6) 31.9 11.1 24.6
Financing Cash Flow 0.2 (107.0) 277.2 (237.6) (4.5) 18.5 (1.2) 30.1 19.8 (4.2)
Cash Position
Net Change in Cash 126.9 (3.6) (565.8) 36.1 257.1 185.5 (1.6) 48.1 71.7 (207.3)
Cash at Beginning 88.6 92.2 657.9 621.9 364.8 179.2 180.8 132.8 54.0 261.3
Cash at End 215.5 88.6 92.2 657.9 621.9 364.8 179.2 180.8 125.7 54.0
Free Cash Flow 127.0 103.4 183.2 273.6 261.6 167.0 3.5 (79.5) (103.8) (129.6)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
Income Statement
Revenue 296.2 351.4 442.7 410.6 413.8 389.5 428.4 346.6 298.3 274.0 149.6 76.4 22.9 150.2 65.9 43.9 36.1 22.2 10.5 3.1
Gross Profit 296.2 343.9 436.6 409.2 343.3 386.4 293.0 313.9 278.9 272.1 149.5 50.9 15.7 149.3 65.9 43.9 36.1 22.2 10.5 0
Operating Income 118.8 93.1 (945.4) 250.3 232.3 142.9 120.1 (238.9) (77.4) (51.9) (102.1) (169.4) (252.0) (72.8) (66.1) (60.8) (72.8) (55.9) (57.6) (39.6)
Net Income 24.0 0.9 (1,002.2) 175.1 528.4 106.2 21.5 (282.4) (116.9) (81.7) (142.7) (189.6) (272.8) (72.6) (64.9) (53.0) (71.2) (53.9) (52.8) (37.2)
EPS (Diluted) 0.15 0.01 -6.45 0.96 3.21 0.66 -0.10 -1.85 -0.78 -0.56 -1.00 -1.39 -2.35 -0.68 -0.65 -0.59 -1.02 -0.77 -0.70 -0.39
Balance Sheet
Cash & Equivalents 215.5 88.6 92.2 656.2 620.1 364.3 177.0 173.2 125.7 54.0 123.1 67.7
Total Assets 396.9 350.9 471.1 1,100.5 1,126.9 559.2 402.7 332.1 605.7 709.8 162.5 140.7
Total Debt 597.8 599.5 715.5 415.9 475.8 453.7 431.2 413.9 400.2 372.8 3.3 2.1
Stockholders' Equity (261.8) (301.3) (346.3) 652.4 605.9 62.6 (93.3) (196.4) 9.8 66.7 (301.6) (235.8)
Cash Flow
Operating Cash Flow 127.0 103.5 183.4 273.8 261.9 168.8 10.7 (70.9) (99.6) (25.4)
Capital Expenditure (0.0) (0.1) (0.3) (0.1) (0.3) (1.8) (7.2) (8.6) (4.2) (104.2)
Free Cash Flow 127.0 103.4 183.2 273.6 261.6 167.0 3.5 (79.5) (103.8) (129.6)